US Stock MarketDetailed Quotes

AGIO Agios Pharmaceuticals

Watchlist
  • 29.100
  • -0.520-1.76%
Close Apr 29 16:00 ET
  • 29.300
  • +0.200+0.69%
Pre 06:49 ET
1.69BMarket Cap2.50P/E (TTM)

Agios Pharmaceuticals Key Stats

Agios Pharmaceuticals Q1 2025 Estimates Date

Currency:USDMay 1, 2025

Estimate YoY
Revenue
9.68M
+18.15%
EPS
-1.75
-20.84%
Buy

Apr 18, 2025

Agios Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 9.987M--
May 1, 20252025/Q1-- / 9.676M--
Feb 13, 20252024/Q410.730M / 9.347M--
Oct 31, 20242024/Q38.964M / 9.502M--
Aug 1, 20242024/Q28.615M / 9.307M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 9.987M--
May 1, 20252025/Q1-- / 9.676M--
Feb 13, 20252024/Q410.730M / 9.347M--
Oct 31, 20242024/Q38.964M / 9.502M--
Aug 1, 20242024/Q28.615M / 9.307M--

Unlock Free Earnings Estimates

Agios Pharmaceuticals Earnings Reports

Read more

Market Insights

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Unlock Now

Discussing

Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks Show More